(Q89389462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Clinical Utility of CLIA-Grade AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Mark C Markowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

John L Silberstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

James R Eshleman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Mario A Eisenberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Jun Luo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Emmanuel S Antonarakis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

30 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

published in

JCO Precision Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

4 April 2020

cites work

1 reference

12 December 2020

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

1 reference

12 December 2020

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

1 reference

12 December 2020

Abiraterone in metastatic prostate cancer without previous chemotherapy

1 reference

12 December 2020

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

1 reference

12 December 2020

Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone

1 reference

12 December 2020

Enzalutamide in metastatic prostate cancer before chemotherapy

1 reference

12 December 2020

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

1 reference

12 December 2020

Serial blood-based analysis of AR-V7 in men with advanced prostate cancer

1 reference

12 December 2020

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells.

1 reference

12 December 2020

Androgen receptor splice variant V7 (AR-V7) in circulating tumor cells: a coming of age for AR splice variants?

1 reference

12 December 2020

Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer

1 reference

12 December 2020

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

1 reference

12 December 2020

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide

1 reference

12 December 2020

Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study

1 reference

12 December 2020

Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting

1 reference

12 December 2020

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

1 reference

12 December 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

1 reference

12 December 2020

Identifiers

DOI

10.1200/PO.17.00127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29170762%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

PubMed publication ID

29170762

1 reference